1 – 10 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
- 2021
-
Mark
Parkinson's Disease with Device, Diary, or in Disguise. Dyskinesia reduction, motor state evaluation, and workforce participation among persons with Parkinson's disease.
2021) In Lund University Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
- 2020
-
Mark
The role of glia in Parkinson's disease : Emerging concepts and therapeutic applications
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2019
-
Mark
Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT1A receptor biased agonists
(
- Contribution to journal › Article
-
Mark
Animal models of l-DOPA-induced dyskinesia : the 6-OHDA-lesioned rat and mouse
(
- Contribution to journal › Article
-
Mark
Circuit-level analyses of cortico-basal ganglia-thalamic networks. Effects of dopamine dysregulation and experience dependent plasticity.
(
- Thesis › Doctoral thesis (compilation)